"We expect reports on all the clinical trials to be submitted to the ministry by September 10," Mikhail Zurabov said.
The minister said that 156 volunteers in St. Petersburg and 200 in Moscow were taking part in the trials.
"The results show a satisfactory tolerance toward the vaccine and a lack of side effects," Zurabov said.
He said 50-60 million doses would be produced and stored in September and in the event of a sudden outbreak Russia could produce 500 million doses quickly.
Leaders of the Group of Eight leading industrialized nations gave their support at the current summit in St. Petersburg to Russia's initiative to build within its territory a World Health Organization center for the fight against bird flu in Eurasia and Central Asia.
